[HTML][HTML] MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?
AA Feduccia, MC Mithoefer - Progress in neuro-psychopharmacology and …, 2018 - Elsevier
MDMA-assisted psychotherapy for treatment of PTSD has recently progressed to Phase 3
clinical trials and received Breakthrough Therapy designation by the FDA. MDMA used as …
clinical trials and received Breakthrough Therapy designation by the FDA. MDMA used as …
[HTML][HTML] A review of 3, 4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy
B Sessa, L Higbed, D Nutt - Frontiers in psychiatry, 2019 - frontiersin.org
This paper provides a brief review of the history, proposed pharmacological mechanisms,
safety issues, and clinical applications of the medicine 3, 4 …
safety issues, and clinical applications of the medicine 3, 4 …
The safety and efficacy of±3, 4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder …
MC Mithoefer, MT Wagner… - Journal of …, 2011 - journals.sagepub.com
Case reports indicate that psychiatrists administered±3, 4-
methylenedioxymethamphetamine (MDMA) as a catalyst to psychotherapy before …
methylenedioxymethamphetamine (MDMA) as a catalyst to psychotherapy before …
3, 4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial
M Ot'alora G, J Grigsby, B Poulter… - Journal of …, 2018 - journals.sagepub.com
Background: Posttraumatic stress disorder often does not resolve after conventional
psychotherapies or pharmacotherapies. Pilot studies have reported that 3, 4 …
psychotherapies or pharmacotherapies. Pilot studies have reported that 3, 4 …
Toxicity of amphetamines: an update
Amphetamines represent a class of psychotropic compounds, widely abused for their
stimulant, euphoric, anorectic, and, in some cases, emphathogenic, entactogenic, and …
stimulant, euphoric, anorectic, and, in some cases, emphathogenic, entactogenic, and …
Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness
Background: Ayahuasca, a traditional Amazonian decoction with psychoactive properties, is
made from bark of the Banisteriopsis caapi vine (containing beta-carboline alkaloids) and …
made from bark of the Banisteriopsis caapi vine (containing beta-carboline alkaloids) and …
Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin
RB Rothman, MH Baumann, CM Dersch… - Synapse, 2001 - Wiley Online Library
A large body of evidence supports the hypothesis that mesolimbic dopamine (DA) mediates,
in animal models, the reinforcing effects of central nervous system stimulants such as …
in animal models, the reinforcing effects of central nervous system stimulants such as …
The pharmacology and toxicology of “ecstasy”(MDMA) and related drugs
H Kalant - Cmaj, 2001 - Can Med Assoc
Abtract" ECSTASY"(MDMA) AND RELATED DRUGS ARE AMPHETAMINE DERIVATIVES
that also have some of the pharmacological properties of mescaline. They have become …
that also have some of the pharmacological properties of mescaline. They have become …
Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition
R De la Torre, M Farré, PN Roset… - Therapeutic drug …, 2004 - journals.lww.com
Abstract MDMA (3, 4-methylenedioxymethamphetamine, ecstasy) is a widely misused
psychostimulant drug abused among large segments of the young population …
psychostimulant drug abused among large segments of the young population …
Comparison of acute lethal toxicity of commonly abused psychoactive substances
RS Gable - Addiction, 2004 - Wiley Online Library
Aims To determine the acute lethal toxicity of a range of psychoactive substances in terms of
the dose customarily used as a single substance for non‐medical purposes. Design and …
the dose customarily used as a single substance for non‐medical purposes. Design and …